Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leprosy.

R R Jacobson1, J L Krahenbuhl

  • 1Division of National Hansen's Disease Programs, Gillis W Long Hansen's Disease Center, Carville, LA 70721-9607, USA. jkrahe1@lsu.edu

Lancet (London, England)
|February 25, 1999
PubMed
Summary
This summary is machine-generated.

Leprosy management has improved, reducing stigma. However, the disease incidence remains stable, and eradication requires ongoing control efforts beyond chemotherapy alone.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alcoholism, Korsakoff's Syndrome and the Frontal Lobes.

Behavioural neurology·2014
Same author

Expression and characterization of recombinant interferon gamma (IFN-gamma) from the nine-banded armadillo (Dasypus novemcinctus) and its effect on Mycobacterium leprae-infected macrophages.

Cytokine·2008
Same author

The continuing challenges of leprosy.

Clinical microbiology reviews·2006
Same author

Outcome of postpartum disorders: a 10 year follow-up of hospital admissions.

Acta psychiatrica Scandinavica·2004
Same author

Viable M. leprae as a research reagent.

International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association·2001
Same author

Copper(I) complexes, copper(I)/O(2) reactivity, and copper(II) complex adducts, with a series of tetradentate tripyridylalkylamine tripodal ligands.

Inorganic chemistry·2001
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
Same journal

Indonesia's health reform: from pandemic mandate to the six pillars of transformation.

Lancet (London, England)·2026
Same journal

LGBTQ+ Russians increasingly avoiding doctors.

Lancet (London, England)·2026
See all related articles

Area of Science:

  • Medical Science
  • Public Health
  • Infectious Diseases

Background:

  • Leprosy, an ancient and feared disease, is often misunderstood.
  • Significant advancements in leprosy management over 30 years have reduced patient stigma and improved outcomes.
  • The World Health Organization's (WHO) goal to eliminate leprosy by 2000 has raised public awareness but also misconceptions about its eradication.

Purpose of the Study:

  • To provide a basic understanding of leprosy and its management for healthcare professionals.
  • To address the persistent incidence of leprosy despite control efforts.
  • To inform physicians about the continued relevance of leprosy diagnosis and management in a mobile global population.

Main Methods:

  • Review of historical data and current trends in leprosy incidence and registered cases.

Related Experiment Videos

  • Analysis of the impact of WHO's elimination goals on public perception and disease control.
  • Assessment of the limitations of chemotherapy alone in eradicating bacterial infectious diseases.

    • Main Results:

    • Despite a decrease in registered cases, the incidence of leprosy has shown minimal change.
    • Public perception has been influenced by the WHO's elimination goal, leading to a belief in eradication.
    • Chemotherapy alone is insufficient for the eradication of leprosy.

    Conclusions:

    • Leprosy is unlikely to be eradicated in the near future solely through chemotherapy.
    • Continued and adequate control efforts beyond the year 2000 are crucial for potentially diminishing leprosy incidence.
    • Physicians worldwide may encounter leprosy cases, necessitating a fundamental understanding of the disease and its management due to patient mobility.